Cycloastragenol Clinical Trials Recruiting Now

Cycloastragenol trials recruiting now

1 registration that name cycloastragenol as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.

Trial Finder Read from ClinicalTrials.gov Oct 20, 2026 The Cycloastragenol supplement page

Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.

Not yet recruitingNCT05598359

TA-65 and Aging Associated Microvascular Dysfunction

No phase
Medical College of Wisconsin
About 180 people
Starts Jan 1, 2027 (estimated)

In plain words A study of cycloastragenol in people 18 to 80, run by Medical College of Wisconsin. It plans to enroll about 180 people and lists no sites yet.

Who it lists and where

Who the trial lists, as registered

Lists people 18 to 80; healthy volunteers accepted. Conditions: Telomere Shortening; Aging; Vascular Diseases.

Healthy Adults 18 - 35 and 65+ years of age
Subjects with clinical diagnosis of CAD

The exclusion criteria are on the listing.

What it tests, as registered

TA-65; Placebo

Registered summary

The goal of this clinical trial is to test whether activation of telomerase with a dietary supplement (TA-65) improves microvascular function.

Where, as registered

No sites listed yet.